closeCreated with sketchtool.
Show all results

Our Shares

At a glance

The performance of our shares was, on the whole, characterized by volatility in 2018: Following a downswing in the first quarter amid a market setting that came under visible pressure, the share price staged a recovery by the year-end. Our share price remained almost unchanged over the previous year at + 0.26%, finishing the year at € 89.98. The shares substantially outperformed the relevant reference indices, which all recorded a downswing during the same period. When compared with the DAX® reference index, which fell by around 18% during the period as a whole, our shares performed just under 19 percentage points better. Their outperformance vis-à-vis the relevant chemical industry index, which fell by almost 16% in 2018, was around 16 percentage points. The pharmaceutical industry index declined by around 3% in 2018, thus underperforming our shares by 3 percentage points in the same period.

In 2018, the Executive Board and the Investor Relations team gave in-depth briefings to more than 660 investors at investor conferences as well as during roadshows and conference calls.

The average daily trading volume of our shares increased by 23% from approximately 474,000 in 2017 to over 584,000 in 2018. The North America region continued to dominate: its proportion of the free float increased to around 36% (2017: 29%). By investor type, growth and value investors dominated, as in the previous year. In 2018, growing interest could be seen among value investors, who now hold approximately 28% of the free float. At the end of 2018, the top five investors held around 28% of the free float (2017: 19%).

Our shares

Share price development from January 1, 2018 to December 31, 2018

in %

Source: Bloomberg (closing rates).
23 KB EXCEL

Our shares

Key share price data1

2018 2017
Dividend2 1.25 1.25
Share price high 99.82 114.40
Share price low 74.80 87.90
Year-end share price 89.98 89.75
Daily average number of shares traded3 number 583,653 473,740
Market capitalization4 (at year-end) € million 39,121 39,021
Market value of authorized shares5 (at year-end) € million 11,629 11,599
1
Share-price relevant figures relate to the closing price in XETRA® trading on the Frankfurt Stock Exchange.
2
2018 dividend subject to approval by the AGM.
3
Based on the floor trading systems of all German exchanges and the regulated market on XETRA®.
4
Based on the theoretical number of shares (434.8 million).
5
Based on the number of shares in free float (129.2 million).
Source: Bloomberg, Thomson Reuters.

Our shares

Identified investors by region as of December 2018

Source: Nasdaq Shareholder Identification.Total number of shares outstanding: 129.2 million.

 

Our shares

Identified investors by type as of December 2018

Source: Nasdaq Shareholder Identification.